Quality of life with palbociclib plus fulvestrant in previously treated hormone receptor–positive, her2-negative metastatic breast cancer: patient-reported outcomes from the PALOMA-3 trial
Home → Pain → Quality of life with palbociclib plus fulvestrant in previously treated hormone receptor–positive, her2-negative metastatic breast cancer: patient-reported outcomes from the PALOMA-3 trial
